Nurlan Utelbayev
Research Subjects
Nurlan Utelbayev has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adil Zhamankulov
NCJSC «Astana medical university», Astana, Republic of Kazakhstan
2 shared publications - Madina Gatauova
NCJSC «Astana medical university», Astana, Republic of Kazakhstan
2 shared publications - Aleksayder Nikolaevich Pampura
Pirogov Russian National Research Medical University
1 shared publication - Alexey Balas
OLYMP Clinical Diagnostic Laboratory LLP, Kazakhstan
1 shared publication - Kseniya Shnayder
Department of Pediatric Diseases №1, Astana Medical University (AMU)", Astana, Republic of Kazakhstan
1 shared publication Marina Morenko
Department of Pediatric Diseases №1, Astana Medical University (AMU)", Astana, Republic of Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Semey Medical University in Наука и здравоохранение
- Vol. 28 (2(28)) , 182-190
RETROSPECTIVE ANALISIS OF POST- COVID SYNDROME OF CHILDREN AFTER SARS-COV-2
Introduction. At the end of December 2019, an outbreak of pneumonia of unknown origin occurred in the city of Wuhan, China. The outbreak was believed to be linked to a local seafood market. In early January 2020, during investigations, a new strain of coronavirus was identified, initially named 2019-nCoV. On February 11, 2020, the virus was officially named SARS-CoV-2, and the disease it causes was named COVID-19. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic as the virus rapidly spread worldwide. Research Objective:To study the clinical and laboratory features of post-COVID syndrome in healthy children who have had SARS-CoV-2. Materials and Methods: A retrospective analysis of 516 medical records and outpatient charts of children who had contracted coronavirus infection between February and August 2020 was conducted. The study included demographic characteristics, clinical manifestations, and laboratory parameters. Statistical analysis was performed using standard biomedical statistical methods. Quantitative variables were presented as mean ± standard deviation (SD), and categorical variables as percentages. Differences were considered statistically significant at p < 0.05. Research Results:A parental survey of children who had recovered from COVID-19 revealed post-COVID-19 syndrome in 33.8% of cases. The predominant symptoms included fatigue, persistent cough, impaired concentration, headaches, and loss of taste and/or smell. Laboratory findings demonstrated reduced levels of vitamin D, leukocytes, lymphocytes, hemoglobin, and ferritin; elevated C-reactive protein (CRP), IgE, and erythrocyte sedimentation rate (ESR); and the presence of anti-SARS-CoV-2 antibodies in 90.2% of the children. Conclusions: Рost-COVID-19 syndrome developed in 33.8% of children following mild or moderate COVID-19, and was characterized by asthenic, respiratory, and cognitive components, accompanied by inflammatory and immunological alterations in laboratory parameters. Введение. В конце декабря 2019 года в городе Ухань, Китай, произошла вспышка пневмонии неизвестного происхождения. Считается, что вспышка была связана с местным рынком морепродуктов. В ходе исследований, проведенных в начале января 2020 года, был идентифицирован новый штамм коронавируса, первоначально названный 2019-nCoV. 11 февраля 2020 года вирус был официально назван SARS-CoV-2, а вызываемое им заболевание получило название COVID-19. 11 марта 2020 года Всемирная организация здравоохранения (ВОЗ) объявила о пандемии COVID-19, поскольку вирус быстро распространялся по всему миру. Цель исследования: изучить особенности клинико-лабораторного течения постковидного синдрома у здоровых детей, перенесших SARS-CoV-2 Материалы и методы: Проведен ретроспективный анализ 516 историй болезни и амбулаторных карт детей, перенесших коронавирусную инфекцию в период с февраля по август 2020 года. Анализ включал демографические характеристики, клинические проявления и лабораторные показатели. Статистическая обработка данных проводилась с использованием стандартных методов биомедицинской статистики. Количественные показатели представлены в виде среднего значения (Mean) ± стандартного отклонения (SD), качественные показатели — в процентах. Статистически значимыми считались различия при p < 0,05. Результаты исследования: Опрос родителей детей, перенёсших COVID-19, выявил постковидный синдром у 33,8% из них. Основные симптомы: слабость, остаточный кашель, снижение концентрации, головные боли, потеря вкуса/обоняния. Лабораторно отмечены снижение витамина D, лейкоцитов, лимфоцитов, гемоглобина, ферритина; повышение СРБ, IgE, СОЭ; антитела к SARS-CoV-2 – у 90,2%. Выводы: Таким образом, у 33,8 % детей, перенесших COVID-19 в лёгкой или среднетяжёлой форме, развивается постковидный синдром, характеризующийся астеническим, респираторным и когнитивным компонентами на фоне воспалительных и иммунологических изменений лабораторных показателей. Кіріспе. 2019 жылдың желтоқсан айының соңында Қытайдың Ухань қаласында шығу тегі белгісіз пневмонияның өршуі болды. Ауру жергілікті теңіз өнімдері нарығымен байланысты деп саналады. 2020 жылдың қаңтар айының басында жүргізілген зерттеулер бастапқыда 2019-nCoV деп аталатын...
- 30 April 2026
- Published by Semey Medical University in Наука и здравоохранение
- Vol. 28 (2(28)) , 182-190
Open AccessRETROSPECTIVE ANALISIS OF POST- COVID SYNDROME OF CHILDREN AFTER SARS-COV-2
Introduction. At the end of December 2019, an outbreak of pneumonia of unknown origin occurred in the city of Wuhan, China. The outbreak was believed to be linked to a local seafood market. In early January 2020, during investigations, a new strain of coronavirus was identified, initially named 2019-nCoV. On February 11, 2020, the virus was officially named SARS-CoV-2, and the disease it causes was named COVID-19. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic as the virus rapidly spread worldwide. Research Objective:To study the clinical and laboratory features of post-COVID syndrome in healthy children who have had SARS-CoV-2. Materials and Methods: A retrospective analysis of 516 medical records and outpatient charts of children who had contracted coronavirus infection between February and August 2020 was conducted. The study included demographic characteristics, clinical manifestations, and laboratory parameters. Statistical analysis was performed using standard biomedical statistical methods. Quantitative variables were presented as mean ± standard deviation (SD), and categorical variables as percentages. Differences were considered statistically significant at p < 0.05. Research Results:A parental survey of children who had recovered from COVID-19 revealed post-COVID-19 syndrome in 33.8% of cases. The predominant symptoms included fatigue, persistent cough, impaired concentration, headaches, and loss of taste and/or smell. Laboratory findings demonstrated reduced levels of vitamin D, leukocytes, lymphocytes, hemoglobin, and ferritin; elevated C-reactive protein (CRP), IgE, and erythrocyte sedimentation rate (ESR); and the presence of anti-SARS-CoV-2 antibodies in 90.2% of the children. Conclusions: Рost-COVID-19 syndrome developed in 33.8% of children following mild or moderate COVID-19, and was characterized by asthenic, respiratory, and cognitive components, accompanied by inflammatory and immunological alterations in laboratory parameters. Введение. В конце декабря 2019 года в городе Ухань, Китай, произошла вспышка пневмонии неизвестного происхождения. Считается, что вспышка была связана с местным рынком морепродуктов. В ходе исследований, проведенных в начале января 2020 года, был идентифицирован новый штамм коронавируса, первоначально названный 2019-nCoV. 11 февраля 2020 года вирус был официально назван SARS-CoV-2, а вызываемое им заболевание получило название COVID-19. 11 марта 2020 года Всемирная организация здравоохранения (ВОЗ) объявила о пандемии COVID-19, поскольку вирус быстро распространялся по всему миру. Цель исследования: изучить особенности клинико-лабораторного течения постковидного синдрома у здоровых детей, перенесших SARS-CoV-2 Материалы и методы: Проведен ретроспективный анализ 516 историй болезни и амбулаторных карт детей, перенесших коронавирусную инфекцию в период с февраля по август 2020 года. Анализ включал демографические характеристики, клинические проявления и лабораторные показатели. Статистическая обработка данных проводилась с использованием стандартных методов биомедицинской статистики. Количественные показатели представлены в виде среднего значения (Mean) ± стандартного отклонения (SD), качественные показатели — в процентах. Статистически значимыми считались различия при p < 0,05. Результаты исследования: Опрос родителей детей, перенёсших COVID-19, выявил постковидный синдром у 33,8% из них. Основные симптомы: слабость, остаточный кашель, снижение концентрации, головные боли, потеря вкуса/обоняния. Лабораторно отмечены снижение витамина D, лейкоцитов, лимфоцитов, гемоглобина, ферритина; повышение СРБ, IgE, СОЭ; антитела к SARS-CoV-2 – у 90,2%. Выводы: Таким образом, у 33,8 % детей, перенесших COVID-19 в лёгкой или среднетяжёлой форме, развивается постковидный синдром, характеризующийся астеническим, респираторным и когнитивным компонентами на фоне воспалительных и иммунологических изменений лабораторных показателей. Кіріспе. 2019 жылдың желтоқсан айының соңында Қытайдың Ухань қаласында шығу тегі белгісіз пневмонияның өршуі болды. Ауру жергілікті теңіз өнімдері нарығымен байланысты деп саналады. 2020 жылдың қаңтар айының басында жүргізілген зерттеулер бастапқыда 2019-nCoV деп аталатын...
- 20 April 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
The region-specific landscape of sensitization to respiratory allergens in the population of Kazakhstan accord based on molecular diagnostics
Introduction. Allergic diseases still remain one of the most common and widespread chronic pathologies of our time, affecting up to 40% of the population. Due to its unique environment, which presents a combination of steppe, desert and mountain ecosystems, the Republic of Kazakhstan is of particular interest for studying regional sensitization features. The use of molecular diagnostic methods, such as ImmunoCAP ISAC, makes it possible to detect sensitization at the level of individual allergenic components and form personalized therapy strategies. Aim: Evaluate epidemiological and regional features of sensitization to respiratory allergens in Kazakhstan for the period 2021-2024 using component allergy diagnostics. Materials and methods: The study embraces 4,745 patients with clinical manifestations of allergic diseases (allergic rhinitis, bronchial asthma, atopic dermatitis) who were tested against the ISAC panel (21 inhaled allergens). Descriptive statistics, Pearson's χ2 criterion, Monte Carlo simulation, and Fisher's exact criterion were used. Outcomes/Results: During the observation period, the median number of sensitizations increased more than sixfold (from 18.0 in 2021 to 113.0 in 2024), indicating an increase in allergic load. The most frequently detected components were rFel d 1 (34.7%), rPhl p 1 (23.0%), nArt v1 (22.8%) and rBet v1 (21.5%). Significant regional differences were identified (p = 0.001): weeds (Ambrosia, Artemisia) prevailed in the southern regions, tree allergens (Betula, Alnus) prevailed in the northern regions, polysensitization prevailed in the central and eastern regions, and a combination of steppe and household allergens prevailed in the western regions. Gender differences did not demonstrate any statistical significance (p > 0.05). Conclusion: The study revealed a substantial increase in sensitization in Kazakhstan and a confirmed geographical stratification of the allergenic spectrum. The results obtained emphasize the need for introduction of regionally adapted diagnostic panels, development of personalized allergen-specific immunotherapy (ASIT) regimens and system monitoring of molecular profile of sensitization for realization of personalized medicine principles.
- 20 April 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
The region-specific landscape of sensitization to respiratory allergens in the population of Kazakhstan accord based on molecular diagnostics
Introduction. Allergic diseases still remain one of the most common and widespread chronic pathologies of our time, affecting up to 40% of the population. Due to its unique environment, which presents a combination of steppe, desert and mountain ecosystems, the Republic of Kazakhstan is of particular interest for studying regional sensitization features. The use of molecular diagnostic methods, such as ImmunoCAP ISAC, makes it possible to detect sensitization at the level of individual allergenic components and form personalized therapy strategies. Aim: Evaluate epidemiological and regional features of sensitization to respiratory allergens in Kazakhstan for the period 2021-2024 using component allergy diagnostics. Materials and methods: The study embraces 4,745 patients with clinical manifestations of allergic diseases (allergic rhinitis, bronchial asthma, atopic dermatitis) who were tested against the ISAC panel (21 inhaled allergens). Descriptive statistics, Pearson's χ2 criterion, Monte Carlo simulation, and Fisher's exact criterion were used. Outcomes/Results: During the observation period, the median number of sensitizations increased more than sixfold (from 18.0 in 2021 to 113.0 in 2024), indicating an increase in allergic load. The most frequently detected components were rFel d 1 (34.7%), rPhl p 1 (23.0%), nArt v1 (22.8%) and rBet v1 (21.5%). Significant regional differences were identified (p = 0.001): weeds (Ambrosia, Artemisia) prevailed in the southern regions, tree allergens (Betula, Alnus) prevailed in the northern regions, polysensitization prevailed in the central and eastern regions, and a combination of steppe and household allergens prevailed in the western regions. Gender differences did not demonstrate any statistical significance (p > 0.05). Conclusion: The study revealed a substantial increase in sensitization in Kazakhstan and a confirmed geographical stratification of the allergenic spectrum. The results obtained emphasize the need for introduction of regionally adapted diagnostic panels, development of personalized allergen-specific immunotherapy (ASIT) regimens and system monitoring of molecular profile of sensitization for realization of personalized medicine principles.